LSP reports first closing of dementia fund

European life sciences investors LSP has closed a new fund to fight dementia at €50m.

Read more

Valneva in talks with EU about 60 million vaccine doses

French Valneva SE announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001.

Read more

Immunocore bags US$75m in Series C round

Immuno-oncology specialist Immunocore plc announced the completion of a $75m Series C private financing round.

Read more

Clariant new year, new CEO

Muttenz-based Clariant announced the appointment of Conrad Keijzer as new Chief Executive Officer,

Read more

EU approves second COVID-19 vaccine

Following a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2.

Read more

Angelini Pharma to take over Arvelle Therapeutics

Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.

Read more

COVID-19 test gives results within minutes

University of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results. 

Read more

Merry Christmas and a Happy New Year

Dear readers,

We wish all visitors to our news page a peaceful and healthy New Year and a successful start to the New Year.  Stay healthy! We will be back with the latest news from 4 January.

Best regards

Your editorial team of European Biotechnology Magazine

Read more

EMA greenlights BioNtech’s COVID-19 vaccine

Following a rapid FDA approval, the European drug authority EMA has recommended to conditionally  approve BioNTech’s mRNA vaccine BNT162b2 in the EU.

Read more

European Circular Bioeconomy Fund growing

Only two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing.

Read more